InsidersTradesSigma
Track the 普洛药业 share price and the full management transaction log of the company, a listed equity based in China. Shares trade on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 普洛药业 has logged 2 insider filings. Market capitalisation: €23bn. The latest transaction was disclosed on 25 April 2023 (Sale). Among the most active insiders: 何春. The full history is free.
2
Insider Decl.
n/a
Thresholds
€196,592
1 ops.
Buy Volume
€15,757
1 ops.
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 11,383 of 28,835 companies
56.9
score / 100
Value52
Quality62
FCF yld3.6%
Earn yld3.9%
EV/EBITDA14.0x
ROE13%
Gross mgn26%
Net mgn9.1%
Debt/EBITDA0.9x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 25 April 2023
About 普洛药业
普洛药业 is a company in the health and pharmaceutical sector, listed on the XSHE market. It focuses on the research, development, and production of innovative medications.